UGC
Market HighlightsIt is estimated that the global neonatal intensive care market is expected to register a CAGR ~5.5% during the forecast period of 2018–2023 with an estimated market value of 9.1 billion in 2017.The global market is driven by factors such as rising prevalence of diseases in new-born children and increasing neonatal population.According to data published by the Centers for Disease Control and Prevention in January 2017, there were 3,945,875 births in the US in 2017.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7513On the other hand, the lack of awareness, high cost of equipment, and lack of skilled professionals is restraining the growth of neonatal intensive care market.For instance, according to a report published by the International Journal of Neonatal Screening in September 2018, the reports of false positive cases in neonates are increasing for various diseases.The global neonatal intensive care unit equipment market is currently dominated by many market players.For instance, PerkinElmer’s QSight 210 MD system launched in September 2016, utilizes tandem quadrupole analysis which provides regular robust screening along with higher sensitivity and faster scanning.Regional AnalysisThe market in the Americas is expected to dominate the global Neonatal Intensive Care market during the forecast period.Also, technological advancements in the industry and government support in terms of National Health Service and health insurance are expected to drive the market growth.Asia-Pacific is estimated to be the fastest growing region in the market due to increased pet adoptions and rise in the number of animal welfare programs.On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income.According to the American Society of Hematology (ASH), it led a campaign to fight sickle cell disease in Africa in June 2018.
UGC
Market Highlights The Ultrasound Probe Disinfection Market is expected to witness tremendous growth owing to the rising demand for disinfectant probes in hospitals, increasing cases of bacterial infection in healthcare center during the treatment, and increasing implementation of high-level disinfection process for critical ultrasound probes.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6642 SegmentationThe Global Ultrasound Probe Disinfection Market is segmented on the basis of product, probe type, by process and end-user.On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, ambulatory care centers, academic & research institutes, and others.Regional AnalysisThe Americas leads in the market owing to the increasing prevalence of rising incidence of bacterial infection, increasing research & development in ultrasound probe disinfection and growing healthcare expenditure.According to the Consumer Report Organization and Centers for Disease Control and Prevention (CDC)  July 2015 publication, it is estimated that every year approximately 648,000 patients in the US got infected by bacteria during a hospital stay, and around 75,000 died.The increasing incidences of bacterial infection may support this market positively.Europe is the second largest ultrasound probe disinfection market during the forecast period due to increasing prevalence of human papillomavirus (HPV).
UGC
The global botulism illness market analysis is expecting a steady growth in coming future.Increasing prevalence of diseases, government support for the research and development and availability of the effective treatment for the botulism illness has driven the growth of the market.Botulism illness is one of the rare and fatal paratactic disorder caused by neurotoxins produced by a bacteria Clostridium botulinum.According to the Centers for Disease Control and Prevention, in US every year, approximately 150 cases, are reported of which 15% are food borne, 65% are infant borne and remaining is caused due to wounds.Continuous increasing awareness and increasing health hygiene of the people helped to minimizing botulism.Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/822  Botulism is generally treated with antitoxin and supportive care.Rising awareness and proper diagnose has meet the expectation of the North America, particularly in the U.S. region.Europe is the second-largest market for botulism illness.Well-developed healthcare sector, increasing healthcare expenditure and increasing awareness among the people are the major factors for the growth of the market in America.Asia pacific region is expected to be fastest growing region in botulism illness market.
UGC
Market HighlightsThe global atrial fibrillation devices market is estimated to account for USD 11123.8 million and registering a CAGR of ~ 11.2 %.Atrial fibrillation is a disorder of the pace or the rhythm of the heart.It is caused by unsystematic electrical activity in the atria of the heart, which causes rapid stimulus of the ventricles, leading to an irregular heartbeat.According to the Centers for Disease Control and Prevention, Atrial fibrillation (AFib) costs the United States about USD 6 billion annually.The lack of technical knowledge and misdiagnosis and mismanagement of the condition may hamper the market growth.Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6520 The global atrial fibrillation market is currently dominated by many market players.For instance, in January 2017, Abbott completed the acquisition of St. Jude Medical, Inc. St. Jude Medical’s strong positions in fast-growing areas such as atrial fibrillation, heart failure, structural heart and chronic pain balance Abbott’s leading positions in coronary interventions and mitral valve disease and will further create a strong and diverse product portfolio.Regional AnalysisThe market in the Americas is expected to dominate the global atrial fibrillation market during the forecast period due to the escalation in the adoption of advanced technologies and procedures for the treatment of atrial fibrillation, and well-developed healthcare infrastructure.
Mike Pence has been in close contact with Marc Short, but will not quarantine, according to a statement provided to Bloomberg News.
8
"Policies designed to replace lost income for unemployed workers ... have been very effective at preventing rental debt," researchers wrote.
10
The Centers for Disease Control and Prevention has linked deli meats sold in multiple states with a serious foodborne illness that has claimed at least one life. A total of 10 cases have been reported under this outbreak, according to the agency, all of which required hospitalization. At this point in time, experts have linked the foodborne illness specifically with … Continue reading
4
UGC
Ischemic heart disease leads to disease such as stable angina, unstable angina, myocardial infarction, and sudden cardiac death.According to the report published by the Centers for Disease Control and Prevention (CDC), in 2016, ischemic heart disease is the one of the top ten leading causes of death in Saudi Arabia regions and account almost 6% death every year.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/2585 The Middle East and Africa Ischemic heart disease Market – OverviewThe Middle East and Africa Ischemic heart disease market are showing the steady growth; mainly owing to increase in consumption of smoking, diabetes mellitus and cholesterol levels.Also, according to the Centers for Disease Control and Prevention (CDC), around 17.7 million people died with CVD, which hold 31% of all global deaths.In this regards, Hamad Medical Corporation, in September 2016, launched heart health campaign, with the aim to educate the public on how to recognize the signs and symptoms of a heart attack and advice on what to do if a heart attack is suspected.These activities help them to keep ahead with their competitor.
UGC
Duodenoscopes Market Information: By Types, (Rigid Duodenoscopes and Flexible Duodenoscopes), By Application, (Diagnosis and Treatment), By End User (Gastrologists, General and Pediatric Surgeons, Hospitals, Speciality Clinics, and Others) – Global Forecast till 2023Global Duodenoscopes Market – OverviewDuodenoscope is flexible, lighted weighted tubes that are released through the mouth, throat, and stomach into the top of the small intestine.Duodenoscopes are being used in more than 650,000 gastrointestinal procedures in the U.S every year.This is a minimally invasive way to drain out fluids from biliary and pancreatic ducts which are blocked by cancerous tumors, gallstones or others.In 2013, the Centers for Disease Control and Prevention (CDC) alerted the FDA regarding possible association of multidrug resistant bacterial infections and duodenoscopes.From January 2013 through December 2014, ERCP was associated with infections in 135 patients.FUJIFILM Holdings Corporation, KARL STORZ GmbH & Co. KG, PENTAX Medical, Olympus Corporation, Custom Ultrasonics, Inc., ENDOMED, and SonoScape and others are some of the prominent players at the forefront of competition in the global duodenoscopes market and are profiled in MRFR Analysis.The market of duodenoscopes is growing moderately.In addition, increasing research and development and technological advancements to identify the causes and risk factors for transmission of infectious agents with duodenoscopes and developing new solutions to minimize patient exposure is another major driver, fuelling the global duodenoscopes market growth.
UGC
Astigmatism is the situation in which patient suffered with blurred vision.It is a refractive error condition in which eyes not able to focus light evenly onto the retina.Normally astigmatism is occurring with condition like myopia and hyperopia, these both condition causes refractive errors because they affect how the eyes bend or “refract” light.Also, according to a report published by the Centers for Disease Control and Prevention in 2015, Around 11 million population of Americas of age 12 years and above improve their vision through proper refractive correction and more than 3.3 million Americans aged 40 years and older are either legally blind or are with low vision.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1734  Global Astigmatism Market – OverviewThe global astigmatism market is showing the significant growth; mainly due to increase in the ageing population, eye injury, eye disease, and surgery.The development has been made by Novartis AG in 2017, Alcon is the division of Novartis and consider as a global leader in eye care, introduce AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with pre-existing corneal astigmatism undergoing cataract surgery.These inventions help companies to meet the requirement of the market and maximize the profit share across the globe.
UGC
Cardiac Mapping Market Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas is anticipated to hold the largest market share owing to the higher adoption rates of cardiac mapping, available healthcare infrastructure, and the presence of prominent players in this region.The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.The cardiac mapping market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.Due to the rising prevalence of cardiovascular diseases and the expansion of healthcare facilities, the market in Asia-Pacific is expected to be the fastest-growing.The cardiac mapping market in the Middle East & Africa has been divided into the Middle East and Africa.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8786Cardiac Mapping Market HighlightsAccording to MRFR analysis, Global Cardiac Mapping Market is expected to register a CAGR of 8.4% during the forecast period of 2019 to 2025 and was valued at USD 1.3 Billion in 2018.The normal heart has a ‘built-in’ electrical system that controls cardiac rhythm and pulse rate.Cardiac arrhythmias such as bradycardia, atrial flutter, and tachycardia can develop due to a sedentary lifestyle, lack of exercise, and other congenital problems.According to the Centers for Disease Control and Prevention (CDC), the prevalence of atrial fibrillation in the US ranged from 2.7 to 6.1 million, which is expected to increase with the ageing population.
As winter approaches, here's a guide to help you assess the coronavirus risk associated with daily activities.
5
UGC
Transradial Access Devices Market Growth, Size and Share Analysis By Product (Catheters, Guidewires), Application (Drug Administration, Blood Transfusion), Disease Area (Cardiovascular Diseases, Cancer, Stroke), End-User (Hospitals, Clinics) – Global Forecast Till 2023The European region is expected transradial access devices market growth due to surging cases of obesity along with the increasing number of chemotherapy procedures and growing use of radial access devices in pediatric patients.The wide scope of application for transradial access devices is a factor that is expected to be responsible for the rapid growth of the market.The global transradial access devices market consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.The Americas dominated the global transradial access devices market owing to the use of transradial access devices for detection of cardiovascular diseases along with the demand for early diagnosis.For instance, a study conducted by the Centers for Disease Control and Prevention (CDC) reported that in 2017, 2.7 to 6.1 million people in the United States have (atrial fibrillation) AFib, leading to more than 750,000 hospitalizations each year in the U.S.The German market is expected to dominate the global transradial access devices market owing to the increase in the prevalence of target diseases coupled with the increasing number of research studies on vascular access devices in Germany.The implementation of various healthcare reforms such as the Patient Protection and Affordable Care Act (PPACA) and high burden of Cardiovascular Diseases (CVDS) in India coupled with the increasing investments in the Asia Pacific region are the factors favoring the growth of transradial access devices in the Asia Pacific regionRequest Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6061The Middle East and Africa is projected to show steady growth in this market due to the strengthening of the healthcare infrastructure in the Middle East and rising prevalence of cancer in Africa along with the subsequent rise in the number of chronic diseases such as cardiovascular diseases, cancer, rheumatoid arthritis, and inflammatory bowel disease.Transradial Access Devices Market SegmentationThe global transradial access devices market is segmented by product, application, disease area, and end-user.Based on product, the global transradial access devices market is classified as catheters, guidewires, sheaths and sheath introducers, accessories, and others.Catheters are further divided into cardiovascular catheters, specialty catheters, intravenous catheters, urinary catheters, and neurological catheters.Guidewires are further classified as solid guidewire and wrapped guidewire.Based on application, the global transradial access devices market is classified as drug administration, fluid and nutrition administration, blood transfusion, and diagnostics and testing.Based on disease area, the global transradial access devices market is classified as cardiovascular diseases, cancer, rheumatoid arthritis, ischemic stroke, endometriosis, and others.Based on end-user, the global transradial access devices market is classified as hospitals, clinics, ambulatory care centers, and others.Transradial Access Devices Market Key PlayersSome of the key players in the global transradial access devices market are Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic Plc (Ireland), Merit Medical System, Inc. (US), Boston Scientific Corporation (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), OSCOR Inc. (US), and others.Browse More Related Research Reports at:Pregnancy Pillow Market Size, Growth | Share Analysis, 2023UTI Treatment Market Size, Growth Analysis | Application, 2023Electrotherapy Market Trends, Size Analysis | Share Value, 2023About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
UGC
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.However, concerns over the adverse effects of macrolide antibiotics such as the gastrointestinal disturbances and adverse hepatic metabolism.Macrolide antibiotics are also reported to worsen cardiac functioning resulting in tachyarrhythmias, and even death in patients, which is hampering the market growth.Global Macrolide Antibiotics Market – SegmentsThe report is segmented into five dynamics to widen the scope of understanding,By Drugs : Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, And Telithromycin among others.By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
More

Top